Clinical use and spectrum of activity
In clinical practice, long-acting systemic sulfonamides occupy an important place due to their broad coverage of infectious pathologies. Physicians may choose these drugs when treating a variety of inflammatory processes.
First, these include purulent-inflammatory lesions of the skin and underlying soft tissues. The drugs show high efficacy in treating severe, slow-healing wounds and ulcers. They are also indicated for pressure ulcers in bedridden patients, abscesses, and furuncles.
Second, respiratory tract infections are a target for this group. These include both inflammations of the bronchial tree (bronchitis) and lesions of the lung tissue (pneumonia).
Third, the drugs successfully combat lower urinary tract infections.
Particular attention should be given to their use in specific and difficult-to-treat infections. This list includes:
- Gonorrhea;
- Trachoma (infectious eye disease);
- Purulent meningitis;
- Drug-resistant malaria (when standard therapy regimens are ineffective).
Pharmacokinetics: why do they act for a long time?
It is crucial for students to understand the pharmacokinetic mechanisms that provide the prolonged effect of these drugs. The main characteristic of long-acting drugs is their very slow elimination from the patient's body.
Why does this happen? The answer lies in the function of the urinary system. After the drug passes through the renal glomeruli, it enters the renal tubule system. It is here that intensive reabsorption takes place—the process of active reuptake of the active substance molecules from the primary urine back into the systemic circulation.
Due to such pronounced tubular reabsorption, the concentration of the drug in the blood decreases extremely slowly. This directly affects the dosing regimen: unlike short-acting drugs, long-acting systemic sulfonamides in most cases need to be prescribed only once a day. This significantly improves patient adherence to the prescribed treatment.
Case study of a specific drug: Sulfalene
To understand clinical nuances, let us examine the drug sulfalene (Sulfalenum) in detail. Its use requires the physician to have a clear understanding of the stage and character of the disease, as the dosing regimen changes radically depending on the situation.
If a patient is suffering from an acute, rapidly progressing infection, sulfalene is prescribed for daily administration. This allows a high therapeutic concentration to be quickly established and maintained at the site of inflammation.
A completely different tactic is used for chronic, prolonged infectious processes. In this case, the pharmacokinetics of the drug are fully realized:
- When taken orally, it is sufficient to prescribe the drug only once every 7–10 days.
- For parenteral administration (intَramuscular or intravenous injections), the drug is administered once a day.
However, the use of sulfalene requires strict vigilance regarding side effects. The most dangerous complication is the development of a severe allergic reaction—Stevens–Johnson syndrome. The physician must warn the patient about possible skin manifestations and immediately discontinue therapy at the first signs of allergy.
Briefly: answers to topical questions
What is the mechanism of the antibacterial action of sulfonamides?
The mechanism of the antibacterial action of sulfonamides consists of the competitive inhibition of the enzyme dihydropteroate synthase. Being structural analogs of para-aminobenzoic acid (PABA), the drugs enter into competitive antagonism with it at the very early stage of synthesis. This leads to the blockade of the formation of dihydropteroic and dihydrofolic acids. As a result, the synthesis of folic acid, which acts as a precursor of purine and pyrimidine bases, is disrupted, which ultimately blocks the synthesis of nucleic acids in the bacterial cell.
Which drugs are included in the group of long-acting and ultra-long-acting sulfonamides?
The group of long-acting and ultra-long-acting sulfonamides includes drugs used for purulent-inflammatory diseases.
The main representatives include:
- Sulfamethoxypyridazine — a long-acting drug.
- Sulfadimethoxine — a long-acting drug.
- Sulfalene — an ultra-long-acting drug.
Sulfalene is characterized by very slow elimination from the body, which is due to its intensive reabsorption in the renal tubules. Due to this, for chronic infections, it can be prescribed orally only once every 7–10 days.
What side effects are characteristic of systemic sulfonamides?
Systemic sulfonamides are characterized by various allergic reactions, organotoxicity, and systemic disturbances.
The main side effects include:
- Allergic reactions — rash, photosensitization, severe Stevens–Johnson syndrome.
- Gastrointestinal tract — dyspeptic disorders.
- Liver — hepatotoxicity.
- Blood system — anemia, leukopenia, thrombocytopenia.
- Kidneys — crystalluria (precipitation of crystals under acidic urine reaction).
- Central nervous system — kernicterus in newborns due to displacement of bilirubin from its bond with albumin.
What is the spectrum of antimicrobial activity of sulfonamides with indication of specific microorganisms?
The spectrum of antimicrobial activity of sulfonamides initially includes gram-positive and gram-negative flora, but widespread acquired resistance to them is now observed.
The drugs retain activity against the following microorganisms:
- Nocardia — specific causative agents.
- Toxoplasma — specific causative agents.
- Chlamydia — specific causative agents.
- Pneumocystis — specific causative agents.
- Malarial plasmodia — specific causative agents.
- Actinomycetes — specific causative agents.
- Escherichia coli — suppressed by drugs acting in the intestinal lumen.
What absolute contraindications exist for the use of systemic sulfonamides?
According to the cited sources, contraindications and restrictions on the use of systemic sulfonamides include:
- Severe liver and kidney function impairments.
- Blood disorders.
- Pregnancy — listed as a contraindication in one source; while another source specifies that sulfonamides belong to category C, except for late pregnancy, during which they belong to category D.
- Newborns — sulfonamides are contraindicated due to the risk of kernicterus: the drugs displace bilirubin from its bond with albumin, increasing the concentration of free bilirubin and the risk of toxic brain damage.
- Hypersensitivity is listed as a general contraindication for antibacterial drugs in the pregnancy source.
Which drug groups do sulfonamides exhibit a clinically significant antagonism with?
Sulfonamides exhibit a clinically significant chemical antagonism with local anesthetics that are derivatives of para-aminobenzoic acid (PABA).
Such drugs include:
- Procaine (novocaine) is a local anesthetic.
- Benzocaine (anesthesine) is a local anesthetic.
Upon hydrolysis of these drugs in the body, PABA is released. It acts as a competitive antagonist to sulfonamides, ultimately neutralizing and significantly weakening their antimicrobial effect.
To remember the characteristics of sulfalene, use the mnemonic: "Acute — every day, Chronic — once a week." And its slow elimination is easily associated with "greedy kidneys," which actively return the drug to the bloodstream (reabsorption).
Class and exam questions
Why are long-acting systemic sulfonamides taken so infrequently?
This is due to their pharmacokinetics. Intensive reabsorption of the drug occurs in the renal tubules, which causes it to be eliminated from the body very slowly and circulate in the blood for a long time.
How does the dosage of sulfalene change when an infection becomes chronic?
In chronic and prolonged infections, oral administration of sulfalene is reduced to once every 7–10 days. However, if the drug is administered parenterally (intravenously or intramuscularly), injections are continued once daily.
What severe complication should be anticipated when prescribing sulfalene?
The main danger is the risk of developing Stevens–Johnson syndrome. This is a severe allergic reaction requiring immediate discontinuation of the drug and medical intervention.
In which specific infections is the prescription of these drugs justified?
They are highly effective in the treatment of gonorrhea, trachoma, purulent meningitis, and are also successfully used in drug-resistant malaria treatment regimens.
What else to study on this topic
- Mechanism of renal tubular reabsorption of sulfonamides at the cellular level
- Pathogenesis and clinical presentation of Stevens–Johnson syndrome
- Combination therapy regimens for drug-resistant malaria
- Pharmacokinetic differences between oral and parenteral administration of sulfalene
- Principles of comprehensive treatment for long-healing ulcers and pressure sores
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Systemic sulfonamides" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.